A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections.|https://dx.doi.org/10.1007/s12602-024-10406-0
Clostridioides difficile infection increases in-hospital mortality, length of stay, and hospital cost but not 30-day mortality in cirrhotic patients.|https://dx.doi.org/10.1111/jgh.16807
Antimicrobial Combinations as Novel Indicators for Clostridioides difficile infection development: Population-Based, Nested Case-Controlled Study in Japan-The Shizuoka Kokuho Database Study.|https://dx.doi.org/10.1016/j.jiac.2024.11.002
Complete genome sequences of toxigenic Clostridioides difficile isolated from Australian feral horses.|https://dx.doi.org/10.1128/mra.01086-24
Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection.|https://dx.doi.org/10.1017/ash.2024.413
Impacts of perR on oxygen sensitivity, gene expression, and murine infection in Clostridioides difficile 630Î” erm.|https://dx.doi.org/10.1101/2024.10.30.621113
The impact of the COVID-19 pandemic on hospital-acquired infections and multi-drug resistant organisms, in comparison to seasonal influenza.|https://dx.doi.org/10.1186/s12879-024-09240-0
Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infection.|https://dx.doi.org/10.1016/j.ijid.2024.107314
Dual RNA-seq study of the dynamics of coding and non-coding RNA expression during Clostridioides difficile infection in a mouse model.|https://dx.doi.org/10.1128/msystems.00863-24
Early Economic Modeling to Inform a Target Product Profile: A Case Study of a Novel Rapid Test for Clostridioides difficile Infection.|https://dx.doi.org/10.1177/23814683241293739
